Acceder Registro /

PABLO PELEGRIN VIVANCOS

Buscador

Vidal-Correoso D, Mateo SV, Munoz-Morales AM, Lucas-Ruiz F, Jover-Aguilar M, Alconchel F, Martinez-Alarcon L, Sanchez-Redondo S, Santos V, Lopez-Lopez V, Rios-Zambudio A, Cascales P, Pons JA, Ramirez P, Pelegrin P, Peinado H, Baroja-Mazo A. Cell-specific Extracellular Vesicles and Their miRNA Cargo Released Into the Organ Preservation Solution During Cold Ischemia Storage as Biomarkers for Liver Transplant Outcomes. Transplantation. 2024 Apr 5. doi: 10.1097/TP.0000000000005008. Online ahead of print. PubMed PMID: 38578699.
AÑO: 2024; IF: 6.2
Molina-Lopez C, Hurtado-Navarro L, Garcia CJ, Angosto-Bazarra D, Vallejo F, Tapia-Abellan A, Marques-Soares JR, Vargas C, Bujan-Rivas S, Tomas-Barberan FA, Arostegui JI, Pelegrin P. Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1beta production. Nat Commun. 2024 Feb 6;15(1):1096. doi: 10.1038/s41467-024-44990-0. PubMed PMID: 38321014.
AÑO: 2024; IF: 16.6
Martinez-Banaclocha H, Garcia-Palenciano C, Martinez-Alarcon L, Amores-Iniesta J, Martin-Sanchez F, Ercole GA, Gonzalez-Lisorge A, Fernandez-Pacheco J, Martinez-Gil P, Padilla-Rodriguez J, Baroja-Mazo A, Pelegrin P, Martinez-Garcia JJ. Purinergic P2X7 receptor expression increases in leukocytes from intra-abdominal septic patients. Front Immunol. 2023 Nov 29;14:1297249. doi: 10.3389/fimmu.2023.1297249. eCollection 2023. PubMed PMID: 38094297; PubMed Central PMCID: PMC10716420.
AÑO: 2023; IF: 7.3
Compan V, Pelegrin P. Measuring IL-1beta Processing by Bioluminescence Sensors: Using a Bioluminescence Resonance Energy Transfer Biosensor. Methods Mol Biol. 2023;2696:47-53. doi: 10.1007/978-1-0716-3350-2_3. PubMed PMID: 37578714.
AÑO: 2023
Baroja-Mazo A, Penin-Franch A, Lucas-Ruiz F, de Torre-Minguela C, Alarcon-Vila C, Hernandez-Caselles T, Pelegrin P. P2X7 receptor activation impairs antitumour activity of natural killer cells. Br J Pharmacol. 2023 Jan;180(1):111-128. doi: 10.1111/bph.15951. Epub 2022 Oct 3. PubMed PMID: 36098250.
AÑO: 2023; IF: 7.3

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R